All Stories

  1. Omega-3 Fatty Acids and Neuroinflammation in Depression: Targeting Damage-Associated Molecular Patterns and Neural Biomarkers
  2. The Efficacy of Omega-3 Fatty Acids as the Monotherapy for Depression: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
  3. Omega-3 polyunsaturated fatty acids in the prevention of relapse in patients with stable bipolar disorder: A 6-month pilot randomized controlled trial
  4. Roles of Omega-3 Polyunsaturated Fatty Acids in Managing Cognitive Impairment in Chronic Obstructive Pulmonary Disease: A Review
  5. The Now and Future of ChatGPT and GPT in Psychiatry
  6. Personalized Medicine of Omega-3 Fatty Acids in Depression Treatment in Obese and Metabolically Dysregulated Patients
  7. Personalized Medicine of Omega-3 Fatty Acids in Depression Treatment in Obese and Metabolically Dysregulated Patients
  8. Psychological Outcomes and Quality of Life of Fibromyalgia Patients with Vitamin D Supplementation—A Meta-Analysis
  9. Omega-3 Polyunsaturated Fatty Acids in Managing Comorbid Mood Disorders in Chronic Obstructive Pulmonary Disease (COPD): A Review
  10. The Clinical Observation of Inflammation Theory for Depression: The Initiative of the Formosa Long COVID Multicenter Study (FOCuS)
  11. Identification of Genetic Variations in the NAD-Related Pathways for Patients with Major Depressive Disorder: A Case-Control Study in Taiwan
  12. Personalised medicine in child and Adolescent Psychiatry: Focus on omega-3 polyunsaturated fatty acids and ADHD
  13. Cortisol and inflammatory biomarker levels in youths with attention deficit hyperactivity disorder (ADHD): evidence from a systematic review with meta-analysis
  14. Efficacy and acceptability of different interventions for acrophobia: A network meta-analysis of randomised controlled trials
  15. Challenges and opportunities for early career child mental health professionals during the COVID19 pandemic
  16. Nutritional Neuroscience as Mainstream of Psychiatry: The Evidence- Based Treatment Guidelines for Using Omega-3 Fatty Acids as a New Treatment for Psychiatric Disorders in Children and Adolescents
  17. Plasma estradiol levels and antidepressant effects of omega-3 fatty acids in pregnant women
  18. Somatic pain associated with initiation of interferon-alpha (IFN-α) plus ribavirin (RBV) therapy in chronic HCV patients: A prospective study
  19. High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels
  20. Major depressive episodes during pregnancy and after childbirth: A prospective longitudinal study in Taiwan
  21. Differences between Japan and Taiwan in the treatment of pregnant women with depressive symptoms by omega-3 fatty acids: An open-label pilot study
  22. Atypical major depressive episode as initial presentation of intracranial germinoma in a male adolescent
  23. Polyunsaturated fatty acids levels and initial presentation of somatic symptoms induced by interferon-alpha therapy in patients with chronic hepatitis C viral infection
  24. Polyunsaturated fatty acids (PUFAs) levels in patients with cardiovascular diseases (CVDs) with and without depression
  25. Omega-3 Fatty Acids in the Prevention of Interferon-Alpha-Induced Depression: Results from a Randomized, Controlled Trial
  26. Serotonin-Norepinephrine Reuptake Inhibitor–Associated Mixed Episode in an Adolescent With Schizoaffective Disorder
  27. View on DSM from Taiwan: transition from IV to 5
  28. Maternal parenting styles and mother–child relationship among adolescents with and without persistent attention-deficit/hyperactivity disorder
  29. Serotonin-Norepinephrine Reuptake Inhibitor Treatment for Tinnitus and Depression
  30. Introducing the concept of modern depression in Japan; an international case vignette survey
  31. Early detection and management of atypical neuroleptic malignant syndrome secondary to aripiprazole
  32. Does the ‘hikikomori’ syndrome of social withdrawal exist outside Japan? A preliminary international investigation
  33. Omega-3 Polyunsaturated Fatty Acids (PUFAs) as the "Mind-Body Interface" in Cardiovascular Diseases and Depression
  34. A case of venlafaxine-induced bruxism alleviated by duloxetine substitution
  35. A Case of Milnacipran-Related Sweating Alleviated by Duloxetine Substitution
  36. Reliability and validity of three Chinese-version tasks of Mayer-Salovey-Caruso Emotional Intelligence Test
  37. Paliperidone overdose in a patient with schizophrenia
  38. Emotional management and 5-HT2A receptor gene variance in patients with schizophrenia
  39. Omega-3 Polyunsaturated Fatty Acids (n-3 PUFAs) in Cardiovascular Diseases (CVDs) and Depression: The Missing Link?
  40. Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) treatment for Isaacs syndrome with depression